- Maternal thrombophilia, as a predictor of the onset of obstetric complications and perinatal losses in women with loss of pregnancy, depending on body weight
Maternal thrombophilia, as a predictor of the onset of obstetric complications and perinatal losses in women with loss of pregnancy, depending on body weight
HEALTH OF WOMAN. 2017.8(124):74–80; doi 10.15574/HW.2017.124.74
Duka Yu. M.
SI «Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine», Dnipro
The article gives a scientific and practical justification for the timely detection of maternal thrombophilia at the stage of pregnancy planning taking into account the phenotype of a woman.
The objective: analysis of the structure of the revealed gene polymorphisms and their effect on the course of the gestational process and the hemostasis system in pregnant women, depending on the phenotype.
Patients and methods. A total of 175 women with a threat of miscarriage at the age of 20 to 41 years were selected, who were recruited and further divided into groups: I clinical group (primary) – 120 (68.6%) women with a threat of miscarriage, body weight, II clinical group (comparisons) – 55 (31.4%) of women with normal body weight (BMI 20-24.9 kg/m2) and with symptoms threatening to bear pregnancy, in which an in-depth study of the state of health was conducted.
Results. The carriage of thrombophilia genes in women with miscarriage was revealed in 100% of cases regardless of body weight. However, it was found that the polymorphism of the F2 gene: 20210 G> A and 3-5 times more often in the F5-Leiden gene: 1691 G> A with hetero- and homozygous polymorphism, respectively, was found to be 6 times more frequent in women with excess body weight, respectively. testified to the relationship between the presence of excess body weight in women and the mutation of the clotting factor F5-Leiden. These women belong to the group of extremely high risk of thrombohemorrhagic complications during pregnancy.
Conclusion. A study on maternal thrombophilia should be conducted at the pre-vaginal stage in order to conduct timely pathogenetically based treatment, with emphasis on treatment in the fertile cycle, which will improve the perinatal outcomes in these women.
Key words: phenotype, pregnancy, loss of pregnancy, obesity, thrombophilia, gestational complications, hemostasis system.
REFERENCES
1. Ailamazyan EK, Zainulina MS. 2010. Hereditary thrombophilia: a differential approach to assessing the risk of obstetric complications. Оbstetrics and gynecology 3:3-9.
2. Kiryushchenkov PA, Shmakov RG, Andamov EV et al. 2013. Algorithm of clinical-gemostaziologic examination in obstetric-gynecological practice. Оbstetrics and gynecology 1:101-106.
3. Bitsadze VO. 2004. Pathogenesis, the principles of diagnosis and prevention of complications of pregnancy, caused by thrombophilia: author's abstract. dis. for academic competition. degree of Dr. med. Sciences: spec. 14.01.01 «Obstetrics and gynecology»: 41.
4. Bondar TP, Muratova AYu. 2012. Genetic factors of development of thrombophilia in pregnant women. Bulletin of the Peoples' Friendship University of Russia. Series «Medicine» 1(1):119-120.
5. Gazieva IА, Chistyakova GN, Kovalev VV. 2013. Polymorphisms of folate metabolism genes and endothelial function indexes in early pregnancy: risk factors for gestational complications development. Obstetrics and Gynecology 1:57-62.
6. Alegina EV, Tetruashvili NK, Agadzhanov AA et al. 2014. Gene polymorphism as a factor predisposing to the usual loss of pregnancy. Obstetrics and gynecology 4:25-31.
7. Makatsariya AD, Beloborodova EV, Bitsadze VO, Baymuradova SM. 2005. Hyperhomocysteinemia and pregnancy complications. Moscow, Triada-X: 216.
8. Trifonova EA, Gabidulina ТV, Agarkova ТА et al. 2011. Homocysteine, polymorphism of the MTHFR gene and complications of pregnancy. Obstetrics and gynecology 2:8-15.
9. Dedov II. 2014. Morbid obesity. Moscow: LLS «MIA»: 608.
10. Dolgushina VF, Vereina NK. 2011. Genetic and acquired factors of thrombosis in women in obstetric pathology in the anamnesis. Obstetrics and Gynecology 3:27-31.
11. Pshenichnikova TB, Peredyayeva EB, Donina EV et al. 2013. Place thrombophilia in the structure of fetal loss syndrome in women with metabolic syndrome. Obstetrics, gynecology and reproductology 7(4):35-43.
12. Makatsariya AD, Pshenichnikova EB, Pshenichnikova ТB, Bitsadze VO. 2006. Metabolic syndrome and thrombophilia in obstetrics and gynecology. Moscow, LLS «MIA»: 480.
13. Momot AP. 2011. Modern methods of recognition of thrombophilic readiness status. Barnaul: Publishing house Altaisk. state. University: 138.
14. Momot AP, Taranenko IA, Tsyvkina LP. 2013. Evolution of ideas about thrombophilia and its role in the problems of human reproduction. Obstetrics and Gynecology 2:4-9.
15. Ozolinya LA. 2008. The importance of hyperhomocysteinemia and the possibility of its correction in obstetrical practice. Health of Ukraine 10:63-66.
16. Fetisova IN, Dobrolyubov AS, Lipin MA et al. 2007. Polymorphism of folate metabolism genes and human diseases. Bulletin of new honey technologies 10(1):23-28.
17. Pshenichnikova EB, Pshenichnikova ТB, Makatsariya AD. 2006. The role of thrombophilia in the development of obstetric pathology in women with metabolic syndrome. Obstetrics and Gynecology 4:15-19.
18. Rebrova OYu. 2002. Statistical analysis of medical data. Application of application of STATISTICA package. M, Media Sfera: 312.